Intelligent Bio Solutions Inc.
INBS· Nasdaq
INBSIntelligent Bio Solutions Inc.
Source filing unavailable
| Metric | Q1 2021 | Q1 2020 |
|---|---|---|
| Revenue | $55.43K | — |
| Net Income | -$1.07M | -$764.83K |
| EPS Diluted | -$0.12 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
